Abstract: The present invention relates to the use of Coenzyme Q10 or functionally equivalent derivatives thereof, through topical or systemic administration, for the prevention, the treatment and/or attenuation of degenerative ocular pathologies, said pathologies being of an heredofamilial, inflammatory, dysmetabolic, senile age-related nature, the degenerative process deriving from apoptotic events caused by hypoxia or other detrimental stimuli due to ischemia or to the lack of trophic factors.
Type:
Grant
Filed:
December 20, 2002
Date of Patent:
April 18, 2006
Assignee:
Giuseppe Simonelli
Inventors:
Rosario Brancato, Giorgio Lenaz, Sergio Capaccioli, Nicola Schiavone
Abstract: In the treatment of ophthalmologic pathologies in general and in particular in the treatment and prevention of side-effects on eye following photorefractive therapy (PRK), laser-assisted in situ keratomileusis (LASIK) and exposure to solar light and ultraviolet radiation, ubiquinone Q10 is utilized in a collyrium pharmaceutical preparation for ocular topical administration thereof.
Type:
Application
Filed:
July 9, 2001
Publication date:
December 25, 2003
Applicant:
Giuseppe Simonelli
Inventors:
Rosario Brancato, Sergio Capaccioli, Marco Fabrizio Saettone, Nicola Schiavone